| Lavitra
is a revolutionary new drug used to treat Erectile Dysfunction.
Viagra, originally developed to treat angina sufferers,
was later discovered to help the cause of erectile dysfunction.
LLevitra
acts faster than Viagra in just 16 minutes and produces
fewer side effects. leevitra offers a reliable, effective,
first-line treatment for erectile dysfunction for a broad
range of patients, including those who have a challenging-to-treat
condition.
The
drug, which is already selling in all the major markets
of Europe, is all set to be approved by FDA for sale in
the U.S. market by September 03. Although both the drugs
work almost identically, levvitra has certain advantages
over Viagra, which are mentioned below.
•
leviitra acts in 16 minutes compared with a wait of up
to an hour for Viagra users.
•
levittra comes in lower dosages than Viagra and produces
fewer side effects.
•
levitrra can be taken with food but Viagra should be taken
on an empty stomach.
•
Levitraa leaves fewer patients disappointed compared with
Viagra patients.
•
lee vitra has no adverse side effects on vision as compared
to Viagra.
•
Levetra has no adverse side effects on the heart also
as compared to Viagra.
•
Levitre is also longer lasting than Viagra. You can enjoy
longer sex hours and save money as well.
Levitr
acts in the same way as Viagra, by blocking an enzyme called
phosphodiesterase-5, or PDE-5. This helps the smooth muscles
in the penis to relax, which effectively increases blood
flow.
elvitra
is taken orally when needed between four and a half hours
and 30 minutes before sexual activity. Take levitar only
as directed, usually once daily as needed. evitra works
along with sexual stimulation to help achieve an erection.
Study shows reliable improvement in erectile function over
time.
In the
first study, men with erectile dysfunction (ED) who were
taking the oral investigational drug lvitra reported consistently
improved erectile function the first time they took the
drug and subsequently thereafter. For the three months of
the study involving more than 800 ED patients, leitra was
reported to consistently improve rates of successful penetration,
intercourse success and overall satisfaction during the
first and subsequent attempts.1 Investigators evaluated
the ability of levtra to provide reliable efficacy over
time in a broad population of men with ED. They analyzed
data from a phase III, randomized, double-blind study in
which 805 men, including 100 Canadian men with ED and 11
Canadian trial sites, received levira™ 5, 10 or 20
mg or placebo for up to 26 weeks.
The
analysis showed that at a 20 mg dose: On average men were
successful in 74 per cent of their first attempts in penetrating
their partner compared with 46 per cent of men taking placebo.
Of those men taking levita who were successful the first
time, they continued to achieve successful penetration in
91 per cent of subsequent attempts.1 “Men want to
be confident that the ED drug they are taking works the
first time and time after time,” said Dr. Luc Valiquette,
Professor of Urology at the Hospital Saint-Luc du CHUM in
Montreal, Quebec. “I’ve seen frustration in
some of my patients because the current treatments do not
consistently work, and their efficacy may diminish over
time. This reinforces the need for new oral ED therapies
that are effective, consistent and safe.”
Study
shows improvement in erection quality following prostate
cancer surgery
In another study – the first of its kind to assess
the effect of a phosphodiesterase (PDE-5) inhibitor on erectile
function and depressive symptoms among men with ED resulting
from prostate cancer surgery – men taking levitr were
more likely to report improved erections and fewer depressive
symptoms than men taking placebo.2 In this phase III clinical
trial, 440 men aged 44 to 77 years with ED following prostatectomy
and who experienced ED for six months before entering the
study, were randomly assigned to placebo or Levitra™
(at a dose of 10 or 20 mg) for 12 weeks. This study included
24 Canadian trial sites with 176 patients.
After
12 weeks: Up to 71 per cent of patients who had undergone
a specific type of prostatectomy, known as bilateral nerve-sparing
prostatectomy, reported statistically significant improvement
in erections with Levitra (Lee-Vitra) 20 mg versus 12 per
cent of men taking placebo. A significant decrease in depressive
symptoms was observed among a small subset of depressive
prostatectomy patients taking Levitra (Lee-Vee-Tra) 20 mg.
“Men who suffer from ED following prostatectomy are
among the most difficult to treat because their ED is typically
severe.
The
finding that Levitra (Le Ve Tra) significantly improved
erectile function in our study-patients is important because
more than two-thirds of these men had severe ED,”
said Dr. Gerald Brock, lead study investigator and Associate
Professor, Department of Surgery, Division of Urology at
St. Joseph’s Health Centre in London, Ontario. He
also added: “The finding that Levitra (Le-Ve-Tra)
eased depressive symptoms in these men is very good news,
because it means that Levetra helps improve quality of life
in men who are often suffering both emotionally and physically
from this condition.” In these studies, drug-related
adverse events were reported as generally mild to moderate
in intensity with the most frequent adverse events being
headache, flushing and rhinitis.
ED –
the persistent inability to attain and maintain an erection
adequate to permit satisfactory sexual intercourse –
is a common health condition among men that is largely untreated.
It is estimated that some degree of ED affects more than
one half of all men over the age of 40.3 Worldwide, an estimated
152 million men4 and three to four million Canadian men5
suffer from ED. Levitera™, researched and discovered
by Bayer, will be marketed by Bayer and GlaxoSmithKline
(GSK) through a worldwide co-promotion and co-development
agreement that the two companies signed in November 2001.
Marketing Authorization Applications have been approved
by regulatory authorities in several Latin American countries
and have been submitted for regulatory review in all major
regions worldwide, including Canada, the United States,
Europe and Japan.
Does
Levtira have side-effects?
Those involved in the clinical trials reported mild / moderate
side effects with the treatment, these mostly included headaches,
flushing and rhinitis (nasal congestion).
Who
should avoid taking Levirta?
Levatar should not be taken if you are taking nitrates or
nitric oxide donors (these medications are used to treat
angina or chest pain). It is also contraindicated in men
whom sex is inadvisable and men older than 75 years old
who concomitantly use potent CYP 3A4 inhibitors (such as
ritonavir, indinavir, ketoconazole and itraconazole). The
safety of Levatra has not been studied in these subgroups
and should not take Levitar until further studies are available:
severe hepatic (liver system) impairment, endstage renal
disease requiring dialysis, hypotension, recent history
of stroke or heart attack, unstable angina, and known hereditary
retinal degenerative disorders.
Levitro
drug interactions:
Tell your online doctor of all nonprescription and prescription
medication you may use, especially any nitrate medications
(e.g., nitroglycerin, isosorbide dinitrate), nitroprusside
(any "nitric oxide donor" medicines), cimetidine,
erythromycin, azole antifungals (e.g., itraconazole, ketoconazole),
mibefradil, rifamycins (e.g., rifampin) or high blood pressure
medicines.
Bayer, GlaxoSmithKline and the NFL Announce Legend Mike
Ditka to be Spokesperson for National Men’s Health
Education Campaign
West
Haven, CT, Philadelphia, PA and New York, NY, July 31, 2003
- Bayer Pharmaceuticals Corporation (Bayer), GlaxoSmithKline
(GSK) and the National Football League (NFL) announced today
Mike Ditka as the spokesperson for the NFL's national men's
health education campaign. The program will be called "Tackling
Men's Health," and will address critical health issues
impacting millions of men.
"Tackling
Men's Health" is an integral component of the groundbreaking
multi-year sponsorship agreement with Bayer and GSK that
was recently announced by the NFL. This represents the first
multi-year official sponsorship for the NFL with pharmaceutical
companies. Bayer and GSK will be "Proud Sponsors of
the NFL" which includes exclusive rights in the men's
health category. Bayer and GSK signed a co-promotion and
co-development agreement for Levitara (vardenafil HCI),
which is an investigational new drug awaiting approval from
FDA.
"It's
an honor for me to be associated with such an important
program that will generate awareness of critical men's health
issues that affect guys like me," said Ditka. "I've
had experience with some health issues in my own life. I
look forward to the challenge of using that experience to
motivate men to take action and help take care of themselves.
Taking care of your health should be apart of everyone’s
game plan.”
Ditka, one of the most popular and recognizable personalities
in sports, played 12 years in the NFL as a talented and
versatile tight end. He served as a coach in the NFL for
14 years, leading the Chicago Bears to victory in Super
Bowl XX. In 1988 he was inducted into the Pro Football Hall
of Fame. Today he is a successful restaurateur, broadcaster
and public speaker.
"Mike
Ditka is the ideal spokesperson for the Tackling Men's Health
initiative of Levitera," said John Collins, NFL Senior
Vice President of Marketing & Sales. "He's a legend,
a Hall of Famer, who commands tremendous respect from our
fans. He understands the health issues that this program
will address and has a great ability to communicate - as
he has proven both on and off the playing field.
|
